STERIS plc Business Acquisition, Pro Forma Revenue
STERIS plc (STE) reported Business Acquisition, Pro Forma Revenue of $4.79 billion for the 12-month period ending 2022-03-31, per its 10-K filed 2023-05-26.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2023-05-26
- STERIS plc business acquisition, pro forma revenue for the quarter ending 2022-03-31 was $1.21B, a 2.73% increase year-over-year.
- STERIS plc business acquisition, pro forma revenue for the quarter ending 2021-12-31 was $1.21B, a 9.26% increase year-over-year.
- STERIS plc business acquisition, pro forma revenue for the quarter ending 2021-09-30 was $1.20B, a 15.62% increase year-over-year.
- STERIS plc business acquisition, pro forma revenue for the quarter ending 2021-06-30 was $1.17B, a 34.91% increase year-over-year.
- STERIS plc business acquisition, pro forma revenue for fiscal 2022 was $4.79B, a 14.32% increase from fiscal 2021.
- STERIS plc business acquisition, pro forma revenue for fiscal 2021 was $4.19B.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2022-03-31 | $1.21B derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $2.42B derived: sum of 2 quarters · filed 2023-05-26 | $3.62B derived: sum of 3 quarters · filed 2023-05-26 | $4.79B 10-K · filed 2023-05-26 |
| 2021-12-31 | $1.21B 10-Q · filed 2022-02-09 | $2.41B derived: sum of 2 quarters · filed 2022-02-09 | $3.58B 10-Q · filed 2022-02-09 | $4.76B derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-09-30 | $1.20B 10-Q · filed 2021-11-08 | $2.37B 10-Q · filed 2021-11-08 | $3.55B derived: sum of 3 quarters · filed 2023-05-26 | $4.66B derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-06-30 | $1.17B 10-Q · filed 2021-08-09 | $2.35B derived: sum of 2 quarters · filed 2023-05-26 | $3.46B derived: sum of 3 quarters · filed 2023-05-26 | $4.49B derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-03-31 | $1.18B derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $2.29B derived: sum of 2 quarters · filed 2023-05-26 | $3.32B derived: sum of 3 quarters · filed 2023-05-26 | $4.19B 10-K · filed 2023-05-26 |
| 2020-12-31 | $1.11B 10-Q · filed 2022-02-09 | $2.14B derived: sum of 2 quarters · filed 2022-02-09 | $3.01B 10-Q · filed 2022-02-09 | |
| 2020-09-30 | $1.04B 10-Q · filed 2021-11-08 | $1.91B 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $869.87M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |